Literature DB >> 7941997

Defective natural killer cell activity and deficient production of interferon-gamma in children with acute lymphoblastic leukemia.

H Wakiguchi1, H Kubota, H Hisakawa, M Fujieda, T Kurashige.   

Abstract

Natural killer (NK) cell activity, OK-432-augmented-NK cell activity, concentrations of interferon-gamma (IFN-gamma) in the culture supernatants of lymphocytes stimulated with OK-432, and subsets of NK cells and memory T cells were analyzed in 42 children with acute lymphoblastic leukemia (ALL) receiving maintenance chemotherapy. Natural killer and augmented-NK cell activities, and concentrations of IFN-gamma in the supernatants of cultured lymphocytes, were significantly lower in the patients with ALL than in age-matched control children. Among the NK cell subsets, proportions of CD57+ cells in the patients with ALL were significantly higher than in the controls, and proportions of a memory T cell subset (CD4+ CD29+ T cells) in the patients were also significantly higher than in the controls. These results suggest that the function of NK cells and memory T cells that are considered as IFN-gamma producing cells, may be defective in ALL, and that CD57+ cells and CD4+ CD29+ cells may be resistant to or recover rapidly from suppression by cytotoxic chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7941997     DOI: 10.1111/j.1442-200x.1994.tb03201.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  3 in total

1.  Non-tuberculous mycobacterial infection in children with cancer.

Authors:  J C Graham; D A Tweddle; D R Jenkins; C Pollitt; S J Pedler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 5.103

Review 2.  Tumor-primed NK cells: waiting for the green light.

Authors:  May Sabry; Mark W Lowdell
Journal:  Front Immunol       Date:  2013-11-25       Impact factor: 7.561

3.  Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia.

Authors:  Sylwia Koltan; Robert Debski; Andrzej Koltan; Elzbieta Grzesk; Barbara Tejza; Andrzej Eljaszewicz; Lidia Gackowska; Malgorzata Kubicka; Beata Kolodziej; Beata Kurylo-Rafinska; Izabela Kubiszewska; Malgorzata Wiese; Milena Januszewska; Jacek Michalkiewicz; Mariusz Wysocki; Jan Styczynski; Grzegorz Grzesk
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.